Showing 281-290 of 1685 results for "".
Incorporating Oxervate Into Your Practice
https://modernod.com/podcasts/to-the-point/incorporating-oxervate-into-your-practice/36900/In this episode of To the Point, Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO, welcome Lauren McLoughlin, OD, to discuss the best methods for incorporating Oxervate (cenegermin-bkbj ophthalmic solution 0.002%, Dompé) into your practice to treat dry eye disease. Dr. McLoughlin provides insigThe Appeal of Aesthetic Optometry
https://modernod.com/podcasts/to-the-point/the-appeal-of-aesthetic-optometry/36899/In this episode of To The Point, hosts Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Carly Rose, OD, FAAO, to discuss her usage of radiofrequency as a treatment option within her practice. Together, they discuss the appeal of aesthetic treatment and IPL, Dr. Rose’s popular social meFour Vital Keys to Success in Collaborative Care Relationships
https://modernod.com/topics/business/four-vital-keys-to-success-in-collaborative-care-relationships/39157/Tips from an OD and MD sharing patients under one roof.2020 Foresight
https://modernod.com/topics/business/2020-foresight/38094/ODs weigh in on their hopes and fears for the post-pandemic future.Adopting Epi-On CXL for KC
https://modernod.com/videos/eye-care-insiders/adopting-epi-on-cxl-for-kc/57127/In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, talks about optometry’s adoption of epithelial-on corneal crosslinking, FDA-approved in late 2025. As the procedure becomes more widely commercially available, Dr. Allen stresses the importance of understanding not only how it differs from epitheA Decade of Developments in Glaucoma Management
https://modernod.com/videos/eye-care-insiders/a-decade-of-development-in-glaucoma-management/37354/Joseph J. Allen, OD, FAAO, Dipl ABO, highlights some of the biggest game-changers in glaucoma management from the past decade, from microinvasive glaucoma surgery to new therapeutics to the acceptance of selective laser trabeculoplasty as a primary therapeutic option for glaucoma.How to (Respectfully) Correct a Patient
https://modernod.com/videos/eye-care-insiders/eci-video-january-2025/37352/Joseph J. Allen, OD, FAAO, Dipl ABO, offers some best practices on an important aspect of patient education: addressing eye care misinformation. He shares several main points to keep in mind for (kindly and professionally) navigating these difficult conversations—especially when a patient insists thTreatment Tactics for RCE
https://modernod.com/topics/corneaanterior-segment/eye-care-insiders-oct-video-2023/37331/Joseph J. Allen, OD, FAAO, Dipl ABO, reviews best practices for the treatment of recurrent corneal erosion (RCE). He discusses conditions that tend to co-occur with RCE, how to diagnose RCE, and strategies for management, along with insights on what treatments have worked well for his patients.Patients Do the Darndest Things …
https://modernod.com/videos/eye-care-insiders/patients-do-the-darndest-things/37340/Joseph J. Allen, OD, FAAO, Dipl ABO, shares a lighthearted top 10 list of things patients do that drive him crazy. Are you familiar with the chin tippers, dramatic photophobes, pull backers, and others that he mentions?Ryzumvi Rundown
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-nov-2023-video/37334/Joseph J. Allen, OD, FAAO, Dipl ABO, spends this episode of Eye Care Insiders discussing phentolamine ophthalmic solution 0.75% (Ryzumvi, Ocuphire Pharma), explaining how it works, reviewing clinical trial findings, potential adverse events, how it could fit into your clinic, and more.